Capricor Therapeutics Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Capricor Therapeutics stock has a consensus rating of "Hold" and an average price target of $4.38. The average 1-year stock price forecast is 13.77% higher than the current stock price, while the lowest is $2.00 (-48.05%) and the highest is $7.00 (+81.82%).

Price Target: $4.38 (+13.77%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$2.00	$4.38	$4.25	$7.00
Change	-48.05%	+13.77%	+10.39%	+81.82%

Analyst Ratings

The average analyst rating for Capricor Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Jan '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	8	8	7	7	8	0
Buy	2	2	2	2	2	0
Hold	0	0	0	0	0	10
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	9	9	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Catherine Novack JonesTrading	JonesTrading	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jul 31, 2026
Madison Elsaadi B. Riley Securities	B. Riley Securities	Hold Downgrades $10 → $5	Hold	Downgrades	$10 → $5	+29.87%	Jul 31, 2026
Jason McCarthy Maxim Group	Maxim Group	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jul 30, 2026
Leland Gershell Oppenheimer	Oppenheimer	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jul 30, 2026
Rick Bienkowski Ladenburg Thalmann & Co.	Ladenburg Thalmann & Co.	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jul 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

64.76M

Revenue Next Year

48.38M

from 64.76M

-25.30%

from 64.76M

EPS This Year

-1.05

from -2.26

EPS Next Year

-1.26

from -1.05

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	244.90K	2.55M	25.18M	22.27M	-	64.76M
Gross Profit	-13.33M	-19.27M	-11.27M	-27.70M	-84.45M	59.25M
Gross Margin	-5,441.51%	-755.07%	-44.76%	-124.37%	-	91.50%
Operating Income	-20.94M	-29.70M	-24.08M	-42.56M	-108.14M	-89.15M
Net Income	-20.02M	-29.02M	-22.29M	-40.47M	-105.04M	-82.36M
EPS	-	-	-	-	-2.26	-1.05
Free Cash Flow	-10.62M	2.34M	-10.92M	-27.78M	-39.60M	-120.00M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	213.3M
Avg	64.8M
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	182.1%
Avg	-25.3%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.70
Avg	-1.05
Low	-2.43

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-